Cargando…

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda

BACKGROUND: Viral load monitoring (VLM) to identify individuals failing antiretroviral therapy (ART) is not widely available in resource-limited settings. We compared the genotypic resistance patterns between clients with VLM versus immunological monitoring (IM). METHODS: Between 2004–2008, 559 ART...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynolds, Steven J, Sendagire, Hakim, Newell, Kevin, Castelnuovo, Barbara, Nankya, Immaculate, Kamya, Moses, Quinn, Thomas C, Manabe, Yukari C, Kambugu, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548731/ https://www.ncbi.nlm.nih.gov/pubmed/23270482 http://dx.doi.org/10.1186/1471-2334-12-381

Ejemplares similares

First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2016)

A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
por: Kiragga, Agnes N., et al.
Publicado: (2019)

Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy
por: Flynn, Andrew G., et al.
Publicado: (2017)

Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings
por: Castelnuovo, Barbara, et al.
Publicado: (2011)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2015)

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2017)

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
por: Tukei, Vincent J, et al.
Publicado: (2013)

Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda
por: Okoboi, Stephen, et al.
Publicado: (2022)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda
por: Billioux, Alexander, et al.
Publicado: (2015)

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda
por: Okoboi, Stephen, et al.
Publicado: (2018)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
por: Sempa, Joseph, et al.
Publicado: (2012)

Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults
por: Mutevedzi, Portia C., et al.
Publicado: (2011)

Free Antiretrovirals Must Not Be Restricted Only to Treatment-Naive Patients: Experience in Uganda suggests that restricting access is not the way forward
por: Colebunders, Robert, et al.
Publicado: (2005)

Prevalence of HIV-Associated Metabolic Abnormalities among Patients Taking First-Line Antiretroviral Therapy in Uganda
por: Omech, Bernard, et al.
Publicado: (2012)

Comparison of Methods for Correction of Mortality Estimates for Loss to Follow-Up after ART Initiation: A Case of the Infectious Diseases Institute, Uganda
por: Kiragga, Agnes N., et al.
Publicado: (2013)

Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
por: Babigumira, Joseph B, et al.
Publicado: (2009)

Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
por: Buzibye, Allan, et al.
Publicado: (2019)

Among Patients with Sustained Viral Suppression in a Resource-Limited Setting, CD4 Gains Are Continuous Although Gender-Based Differences Occur
por: Sempa, Joseph B., et al.
Publicado: (2013)

Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort
por: Weissberg, Dana, et al.
Publicado: (2018)

Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China
por: Zheng, Junwen, et al.
Publicado: (2014)

Acceptability, perceived reliability and challenges associated with distributing HIV self‐test kits to young MSM in Uganda: a qualitative study
por: Okoboi, Stephen, et al.
Publicado: (2019)

Sub-Optimal Vitamin B-12 Levels among ART-Naïve HIV-Positive Individuals in an Urban Cohort in Uganda
por: Semeere, Aggrey S., et al.
Publicado: (2012)

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2018)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda
por: Kaleebu, Pontiano, et al.
Publicado: (2015)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
por: Bunnell, Kristen L., et al.
Publicado: (2018)

Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy
por: Manabe, Yukari C., et al.
Publicado: (2012)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
por: Szubert, Alexander J., et al.
Publicado: (2017)

Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Bending the Arc towards Equitable Partnerships in Global Health and Applied Training
por: Martin, Nina A., et al.
Publicado: (2019)

Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis
por: Manabe, Yukari C., et al.
Publicado: (2012)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
por: Paton, Nicholas I, et al.
Publicado: (2017)

Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti
por: Charles, Macarthur, et al.
Publicado: (2012)

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar
por: Bermúdez-Aza, Elkin Hernán, et al.
Publicado: (2018)

Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
por: Piloya, Thereza, et al.
Publicado: (2012)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
por: Worodria, William, et al.
Publicado: (2011)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agr2ukudhobkibuphkdeds17qf